LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
Re: Methergine and FDA
From:
Barbara Berges <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Wed, 25 Jul 2012 16:49:27 -0400
Content-Type:
text/plain
Parts/Attachments:
text/plain (21 lines) 
Here is a link to a letter from the FDA to Novartis, the manufacturer of
this drug.  Apparently the company applied to change the prescribing
information and the FDA approved the changes.  It does not mention any new
information that led to this change in labeling.

http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/006035s078ltr.pdf

Barb Berges, BS, RN, IBCLC
near Cleveland, Ohio

             ***********************************************

Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome

ATOM RSS1 RSS2